TB Enigma Dynamic Growth Fund

Dealing Line 0115 988 8286. Also available through stockbrokers, wealth managers and platforms
Now available through Hargreaves Lansdown

Fund Summary

The TB Enigma Dynamic Growth Fund is a UK-domiciled UCITS Fund managed by Ekins Guinness LLP. The Fund invests in a portfolio of Exchange Traded Funds (ETFs). The Manager’s decisions are driven by its proprietary data-driven “Enigma Investment Radar” system which determines dynamic asset allocations:

  • between equities, bonds and cash
  • within equities by region and sector
  • within bonds by region
  • with a currency overlay

Key Features

Key features of the Fund are:

  • The dynamic asset allocation policy and rotation across regions and global sectors means that the Fund can adapt to different market conditions
  • The Fund can be fully invested in equities when fundamental value is attractive and/or when trends and momentum are supportive, but can reduce its allocation significantly (even to zero) if an equity bear market is expected
  • Equity investments are normally implemented via regional and global sector ETFs
  • Bond investments are normally implemented via sovereign and aggregate bond ETFs in major regions
  • It adopts a currency overlay which may from time to time hedge non-sterling currency exposures back into sterling and which may also seek to enhance returns
  • Use of ETFs enables flexible exposure to asset classes, regions and sectors; it also reduces stock specific risk and keeps costs low

Investment Methodology

The allocations to the Model are determined by our proprietary “Enigma Investment Radar” which adopts a data-driven methodology based on fundamental value and market trends. The Enigma Investment Radar acts as an objective navigational tool to identify investment opportunities independently of opinion, forecasts and emotion.

 

Structure: UK Authorised OEIC
UCITS: Yes
Authorised Corporate Director: T. Bailey Fund Services
Administrator / Registrar: T. Bailey Fund Services
Depositary: NatWest
Custodian: Northern Trust
Auditor: Deloitte UK
Annual Management Charge and Ongoing Charge Figure (OCF): Fixed Annual Management Charge of 0.7% per annum. Other fees are zero. Estimated weighted average OCF of underlying ETFs for typical portfolio allocation is 0.21%, giving total estimated OCF for Fund of 0.91%
Minimum Investment: £5,000
Share Classes: GBP
Income / Accumulation: Both
Dividend Payment Dates: 31 January and 31 July
Sector: IA Flexible
Valuation: 12 noon daily
Deal cut off: 12 noon daily
ISA Eligible: Yes
ISIN (Acc) GB00BD8YW428
ISIN (Inc) GB00BD8YW758

Disclaimer and Risk Warning

The value of investments can go down and investors could lose all or substantial parts of their investments. Full details of the TB Enigma Dynamic Growth Fund, including risk warnings, are published in the Prospectus and Supplementary Information document. The TB Enigma Dynamic Growth Fund is exposed to global financial markets and therefore is subject to market fluctuations and other risks inherent in such investments. Investments in overseas markets may be affected by changes in exchange rates, which could cause the value of your investment to increase or diminish. The manager may enter into derivative transactions for efficient portfolio management purposes (including hedging) and investment purposes. Performance returns and statistics shown in this website or Fund documents may be simulated. Actual or simulated past performance are not reliable indicators of future performance. You should not treat this website or attached documents as a recommendation to buy, sell or trade the Fund or any of the investments mentioned. Readers of this website or attached documents should conduct their own due diligence and research before making their own investment decision.

DISCLAIMER & RISK WARNING: The value of investments can go down and investors could lose all or substantial parts of their investments. Full details of the TB Enigma Dynamic Growth Fund, including risk warnings, are published in the Prospectus and Supplementary Information document. The TB Enigma Dynamic Growth Fund is exposed to global financial markets and therefore is subject to market fluctuations and other risks inherent in such investments. Investments in overseas markets may be affected by changes in exchange rates, which could cause the value of your investment to increase or diminish. The manager may enter into derivative transactions for efficient portfolio management purposes (including hedging) and investment purposes. Performance returns and statistics shown in this website or Fund documents may be simulated. Actual or simulated past performance are not reliable indicators of future performance. You should not treat this website or attached documents as a recommendation to buy, sell or trade the Fund or any of the investments mentioned. Readers of this website or attached documents should conduct their own due diligence and research before making their own investment decision.

 

The TB Enigma Dynamic Growth Fund is not available to US persons.

Ekins Guinness LLP is authorised by the Financial Conduct Authority for professional customers and eligible counterparties only. Ekins Guinness LLP is not authorised for retail customers.

In order to proceed to this section of the website, please confirm that you are a non-US professional customer.

Full details of the TB Enigma Dynamic Growth Fund, including risk warnings, are published in the Prospectus and Supplementary Information document. The TB Enigma Dynamic Growth Fund is exposed to global financial markets and therefore is subject to market fluctuations and other risks inherent in such investments. Investments in overseas markets may be affected by changes in exchange rates, which could cause the value of your investment to increase or diminish. The manager may enter into derivative transactions for efficient portfolio management purposes (including hedging) and investment purposes.